ArticleResearch in pharmaceutical sciences2026

Aptamer targeting proprotein convertase subtilisin/kexin type 9:

Yaser Eshaghi Milasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.